Atlas Trials

Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M Mutations Detected in Plasma Ct-DNA

Clinical trial NCT02811354 · UNKNOWN

Trial details

NCT number
NCT02811354
Sponsor
National University Hospital, Singapore
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2017-02-24
Primary completion
2019-02-24
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.